Xeris Biopharma Holdings
XERS
XERS
143 hedge funds and large institutions have $182M invested in Xeris Biopharma Holdings in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 134 → 143 (+9)
1.99% more ownership
Funds ownership: 40.91% → 42.9% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
143
Holding in Top 10
2
Calls
$1.26M
Puts
$340K
Top Buyers
| 1 | +$6.23M | |
| 2 | +$5.75M | |
| 3 | +$3.2M | |
| 4 |
Morgan Stanley
New York
|
+$2.12M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.72M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$1.65M | |
| 3 | -$1.33M | |
| 4 |
Lazard Asset Management
New York
|
-$735K |
| 5 |
Millennium Management
New York
|
-$715K |